Literature DB >> 28848163

Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195.

Dapeng Wu1, Yong Li2, Huixiang Zhang1, Xigang Hu1.   

Abstract

BACKGROUND/AIMS: Plasmacytoma variant translocation 1 (PVT1) exerts an oncogenic role in many tumors, including lung cancer. However, the roles of PVT1 in regulating radiosensitivity of NSCLC and its underlying mechanism are still unclear.
METHODS: Expression levels of PVT1 and miR-195 in NSCLC tissues and cells were examined by qRT-PCR. Effects of PVT1 and miR-195 on cell proliferation, apoptosis and colony formation abilities were assessed by MTT assay, flow cytometry and colony formation assay. Luciferase reporter assay was performed to confirm the relationship between PVT1 and miR-195. Tumor xenograft experiments were conducted to observe the effect of PVT1 on radiosensitivity of NSCLC in vivo.
RESULTS: PVT1 was negatively correlated with miR-195 expression in NSCLC tissues and associated with poor prognosis of NSCLC patients. Expression of PVT1 and miR-195 varied inversely after irradiation in NSCLC cells. PVT1 knockdown or miR-195 overexpression enhanced radiosensitivity of NSCLC in vitro by inhibiting proliferation and inducing apoptosis. PVT1 directly interacted with miR-195 and regulated its expression. Moreover, PVT1 knockdown improved radiosensitivity of NSCLC cells in vitro and in vivo by sponging miR-195.
CONCLUSION: Knockdown of PVT1 enhances radiosensitivity of NSCLC by sponging miR-195, providing a novel therapeutic target to improve radiotherapy efficiency in NSCLC.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Lncrna; MiR-195; NSCLC; PVT1; Radiosensitivity

Mesh:

Substances:

Year:  2017        PMID: 28848163     DOI: 10.1159/000480209

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  48 in total

1.  Construction and Verification of a Hypoxia-Related 4-lncRNA Model for Prediction of Breast Cancer.

Authors:  Ye Zhao; Lixiao Liu; Jinduo Zhao; Xuedan Du; Qiongjie Yu; Jinting Wu; Bin Wang; Rongying Ou
Journal:  Int J Gen Med       Date:  2021-08-17

Review 2.  The Mechanism of Long Non-coding RNA in Cancer Radioresistance/Radiosensitivity: A Systematic Review.

Authors:  Wenhan Wu; Shijian Zhang; Jia He
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

3.  Inhibition of lncRNA RET enhances radio-sensitivity of tumor cells via miR-3179/Slug/PTEN axis.

Authors:  Xinxin Liang; Xueping Li; Ping Wang; Zhongmin Chen; Ziyan Yan; Xingkun Ao; Yuhao Liu; Jiaojiao Zhu; Tingting Xi; Shenghui Zhou; Zhongqiu Li; Chao Li; Maoxiang Zhu; Ping-Kun Zhou; Yongqing Gu
Journal:  Toxicol Res (Camb)       Date:  2022-04-01       Impact factor: 2.680

Review 4.  Prognostic values of long noncoding RNA PVT1 in various carcinomas: An updated systematic review and meta-analysis.

Authors:  Meizhu Xiao; Ying Feng; Chongdong Liu; Zhenyu Zhang
Journal:  Cell Prolif       Date:  2018-09-05       Impact factor: 6.831

5.  Hypoxia induces the activation of hepatic stellate cells through the PVT1-miR-152-ATG14 signaling pathway.

Authors:  Fujun Yu; Buyuan Dong; Peihong Dong; Yanghuan He; Jianjian Zheng; Ping Xu
Journal:  Mol Cell Biochem       Date:  2019-12-21       Impact factor: 3.396

6.  LncRNA OGFRP1 promotes cell proliferation and suppresses cell radiosensitivity in gastric cancer by targeting the miR-149-5p/MAP3K3 axis.

Authors:  Huihao Qin; Xing Li; Wei Zhang; Zhiqiang Ding
Journal:  J Mol Histol       Date:  2022-01-20       Impact factor: 2.611

Review 7.  Long and short non-coding RNA and radiation response: a review.

Authors:  Jared M May; Michelle Bylicky; Sunita Chopra; C Norman Coleman; Molykutty J Aryankalayil
Journal:  Transl Res       Date:  2021-02-11       Impact factor: 10.171

8.  Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model.

Authors:  Molykutty J Aryankalayil; Shannon Martello; Michelle A Bylicky; Sunita Chopra; Jared M May; Aman Shankardass; Laurel MacMillan; Landy Sun; Jaleal Sanjak; Claire Vanpouille-Box; Iris Eke; C Norman Coleman
Journal:  J Transl Med       Date:  2021-08-07       Impact factor: 5.531

9.  The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1.

Authors:  Haihua Wu; Yueyue Wang; Tiantian Chen; Yu Li; Haifeng Wang; Lingyu Zhang; Sulian Chen; Wenrui Wang; Qingling Yang; Changjie Chen
Journal:  Biosci Rep       Date:  2018-10-17       Impact factor: 3.840

10.  Pan-cancer characterization of long non-coding RNA and DNA methylation mediated transcriptional dysregulation.

Authors:  Zhen Yang; Feng Xu; Haizhou Wang; Andrew E Teschendorff; Feng Xie; Yungang He
Journal:  EBioMedicine       Date:  2021-05-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.